Cellthera Clinic is a Czech clinic whose activities are focused on the treatment of patients using the principles of regenerative medicine. According to modern research, platelets, immune cells and patients’ own stem cells have significant potential in the treatment of a wide variety of diseases — from age-related degenerative diseases to chronic infectious processes.
This clinic has 15 years of experience in using its own patented technology for isolating stem cells not only from fat, which is standard practice, but also from connective tissue. Thus, from these tissues, in addition to stem cells directly, it is possible to isolate several types of auxiliary cells and special cellular factors that are isolated by these types of cells. When all these proteins and cellular factors are introduced into the patient’s body, together they act much more effectively than stem cells alone
During the existence of the clinic, it was possible to identify areas in which the researchers of the Cellthera clinic were able to particularly succeed:
- vascular surgery and angiology;
- chronic wounds;
- oncology and immunology;
- orthopedics and traumatology;
- plastic and aesthetic surgery;
- sports medicine.
Cellthera Clinic has a successful clinical experience in the use of platelet plasma, stem and dendritic cells isolated from the patient’s body or donated for the treatment of diseases and develops scientific activities in this field.
FAQ
1. What laboratory tests do I need to take for treatment?
All patients must necessarily take:
- General blood test;
- Biochemical blood analysis;
- Coagulogram.
If treatment of oncological or immunological diseases is required, an immunogram is also required.
2. How many courses are needed for treatment?
This is an individual question that depends on many factors. In most cases, in order to achieve noticeable results, it takes 2-4 courses. In some cases, this amount is sufficient, sometimes a full course of radical treatment of 4-8 courses is required, for some patients 1-2 maintenance courses per year are required.
3. Can patients transfer tumor material for the manufacture of vaccines if the operation was performed in another region/country?
This is possible, but for this part of the tumor should not be turned into histological material, but cryofrozen and stored in a special container with liquid nitrogen. In this case, there are no restrictions on the shelf life of the material.